+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Buccal Cavity Devices Market by Product Type, Drug Class, Technology, End User, Application - Global Forecast to 2030- Product Image
Buccal Cavity Devices Market by Product Type, Drug Class, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Buccal Cavity Devices Market by Product Type, Drug Class, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715556
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Buccal Cavity Devices Market grew from USD 3.37 billion in 2024 to USD 3.73 billion in 2025. It is expected to continue growing at a CAGR of 10.58%, reaching USD 6.16 billion by 2030.

Discovering the Promise of Buccal Cavity Delivery

Buccal cavity delivery systems have emerged as a pivotal innovation in drug administration, offering a direct route to systemic circulation that bypasses first-pass metabolism and enhances therapeutic efficacy. As patients and clinicians alike seek more convenient, minimally invasive options, these devices unify patient compliance with robust pharmacokinetic performance. Recent progress in formulation science, from mucoadhesive films to advanced gel matrices, underscores the sector’s commitment to precision dosing and rapid onset of action.

This executive summary provides a comprehensive overview of market dynamics shaped by evolving regulatory landscapes, technological breakthroughs, and shifting patient needs. It explores how novel polymers and nanoparticle approaches elevate bioavailability, how evolving reimbursement models influence adoption, and how patient-centric design is redefining device usability. By synthesizing critical intelligence on drivers, challenges, and strategic imperatives, this report lays the groundwork for informed decision-making among stakeholders seeking to capitalize on this burgeoning field.

Emerging Forces Reshaping the Buccal Device Landscape

The buccal device market is experiencing a period of rapid transformation as emerging technologies, regulatory refinements, and shifting patient expectations converge. Advances in mucoadhesive polymers and nanoparticle-enhanced formulations have reshaped the performance benchmarks for bioavailability and sustained release. Concurrently, digital integration, such as sensor-enabled dosage tracking, is redefining adherence monitoring and enabling remote therapeutic oversight.

Regulators worldwide are clarifying pathways for approval of complex drug-device combinations, reducing time to market and fostering greater competition. In turn, strategic partnerships between academic research centers and commercial innovators are accelerating translational efforts, from bench to bedside. Equally, the rise of precision medicine has intensified demand for personalized dosing solutions, prompting manufacturers to explore modular, customizable platforms. These convergent forces are collectively driving an unprecedented shift in how buccal cavity treatments are conceived, developed, and delivered.

2025 Tariff Shifts Redefining United States Market Dynamics

The introduction of new tariffs in 2025 has imposed significant cost pressures across supply chains reliant on imported raw materials and finished buccal delivery devices. Manufacturers face higher import duties on specialized polymers and active pharmaceutical ingredients originating from key trading partners, compelling many to reevaluate sourcing strategies or absorb increased operational expenses. These duties have also influenced distribution margins, with some end users negotiating price concessions to mitigate financial burden.

Adapting to this landscape has spurred strategic responses, including reshoring production to tariff-exempt regions, diversifying supplier portfolios, and advancing in-house formulation development. Companies with vertically integrated manufacturing capabilities appear better positioned to control costs and maintain competitive pricing. Furthermore, some stakeholders are reallocating R&D budgets to optimize formulations for cost-effective excipients, thereby attenuating the downstream impact of sustained tariff pressures.

Unveiling Key Segments Driving Market Evolution

Product-based analysis reveals that buccal films, including mucoadhesive variants designed for prolonged contact and soluble formats optimized for rapid dissolution, command substantial market share owing to their ease of use and precise dose control. Buccal patches leveraging matrix and reservoir technologies offer versatile release profiles, meeting requirements for both steady sustained delivery and targeted burst release. Controlled-release tablets coexist alongside instant-release formulations, serving distinct therapeutic windows and patient adherence scenarios. Gel platforms, whether formulated as bioadhesive matrices or hydrogels, provide adaptable viscosity and mucosal residence times that cater to diverse clinical needs. Meanwhile, metered-dose and multi-dose oral sprays deliver rapid onset through fine mist aerosolization.

Drug class segmentation underscores the prevalence of hormone therapies and local anesthetics, while nicotine replacement and opioid-based analgesics maintain robust research pipelines. Conventional delivery approaches continue to dominate, but nanoparticle-enhanced systems are gaining traction, particularly for high-potency actives. Home healthcare environments exhibit strong uptake driven by patient self-administration, whereas hospital settings prioritize high-precision, clinician-administered devices. Retail pharmacy channels support widespread availability and OTC adoption. Cardiovascular treatment applications leverage stable polymer matrices to ensure consistent dosing, and hormone replacement therapies are tailored for estrogen and testosterone regimens. In infectious disease management, antimicrobial polymers and antiviral agents benefit from prolonged mucosal retention, and acute and chronic pain management solutions address varying analgesic demands. Smoking cessation efforts hinge on controlled nicotine delivery profiles designed for gradual tapering.

Regional Perspectives Illuminating Global Trends

In the Americas, robust reimbursement frameworks, early adoption of innovative drug delivery technologies, and a mature pharmaceutical ecosystem have cultivated a high-growth environment. Patient preference for self-administered therapies and widespread healthcare infrastructure bolster demand for buccal devices. Conversely, Europe, the Middle East, and Africa display heterogeneity driven by regulatory divergence and varied market access dynamics. In Western Europe, streamlined approval pathways enhance product introductions, while regions in the Middle East are rapidly embracing novel modalities amid public health initiatives. Africa, though nascent in adoption, offers untapped potential via expanding healthcare coverage and partnerships with global health organizations.

Asia-Pacific remains a focal point for long-term growth, propelled by rising healthcare expenditure, expanding middle-class populations, and government support for domestic pharmaceutical manufacturing. Regulatory bodies in key markets are harmonizing standards with global best practices, reducing barriers to entry for advanced formulations. Collaborative research ventures between regional biotech firms and multinational corporations further accelerate localized innovation. Together, these regional forces delineate a dynamic global tapestry of opportunity for stakeholders charting their strategic trajectories.

Competitive Landscape Spotlight on Leading Innovators

The competitive arena is defined by a mix of established pharmaceutical giants and agile specialized innovators. Leading players have fortified their portfolios through targeted acquisitions, expanded R&D footprints, and cross-sector collaborations that integrate digital health capabilities. Industry stalwarts leverage scale to optimize manufacturing efficiency and negotiate favorable supplier contracts, while emerging biotechs differentiate through niche formulation expertise and rapid prototyping capabilities.

Key market actors are intensifying focus on nanoparticle-enabled platforms and advanced mucoadhesive vehicles to secure first-mover advantages in high-value therapeutic segments. Strategic alliances with contract research organizations and technology providers are commonplace, enabling quick iteration and accelerated regulatory submission. Moreover, cross-licensing agreements have become a strategic tool for broadening geographic reach without incurring significant capital expenditure. This fluid competitive landscape rewards those who can marry technical innovation with operational agility and market insight.

Strategic Imperatives for Industry Advancement

Industry leaders should prioritize investment in nanoparticle-enhanced delivery platforms to capture early adoption benefits and demonstrate superior pharmacokinetics. Establishing strategic supply chain partnerships or building regional manufacturing hubs can mitigate tariff-related risks while ensuring continuity of supply. Collaboration with academic institutions and contract research specialists will strengthen the innovation pipeline and expedite time to market. Equally, engaging proactively with health authorities to shape emerging regulatory frameworks will yield competitive advantages and prevent potential compliance bottlenecks.

A regionalized market approach is essential: customizing formulations to meet local clinical needs, reimbursement criteria, and patient preferences will drive adoption. Leaders should consider modular product architectures that can be adapted swiftly across therapeutic areas, from cardiovascular care to hormone replacement and pain management. Finally, integrating digital adherence and remote monitoring tools will enhance patient engagement and unlock new value propositions for payers and providers alike.

Robust Methodology Underpinning the Research Insights

This analysis is underpinned by a rigorous mixed-methodology framework that integrates primary and secondary research components. Primary insights were gathered through in-depth interviews with senior executives, formulation scientists, and regulatory specialists to capture forward-looking perspectives on innovation trajectories and market entry strategies. Complementing this qualitative input, secondary research drew upon peer-reviewed publications, patent databases, and industry reports to validate technical milestones and historical market patterns.

Quantitative data was obtained from company financial disclosures, healthcare expenditure databases, and procurement records. Triangulation techniques were applied to reconcile disparate data sources, ensuring consistency and accuracy. Analytical models were tailored to adjust for regional variances in pricing, tariff impacts, and regulatory timelines. Ongoing validation rounds with subject-matter experts fortified the reliability of the findings and refined the actionable recommendations presented herein.

Synthesis of Insights and Strategic Outlook

The buccal cavity device sector is poised for accelerated expansion, driven by converging technological advances, shifting regulatory landscapes, and evolving patient needs. The 2025 tariff environment has intensified supply chain scrutiny, but strategic adaptations around regional manufacturing and efficient sourcing have mitigated adverse effects. In parallel, segmentation analysis highlights diverse opportunities across product formats, therapeutic classes, and end-user channels, signaling robust potential in chronic pain, hormone therapies, and infectious disease applications.

Regional insights reveal a mature yet dynamic Americas market, a heterogeneous EMEA landscape, and a high-growth Asia-Pacific region. Competitive dynamics emphasize the importance of innovation at scale and operational agility. Moving forward, stakeholders equipped with nuanced understanding of segment-specific drivers and regulatory pathways will be well positioned to harness emerging opportunities. This report crystallizes the essential trends, risks, and strategic levers required to navigate the buccal device landscape effectively.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Buccal Film
      • Mucoadhesive Film
      • Soluble Film
    • Buccal Patch
      • Matrix Patch
      • Reservoir Patch
    • Buccal Tablet
      • Controlled-Release Tablet
      • Instant-Release Tablet
    • Gel
      • Bioadhesive Gel
      • Hydrogel
    • Oral Spray
      • Metered-Dose Spray
      • Multi-Dose Spray
  • Drug Class
    • Hormones
    • Local Anesthetics
    • Nicotine
    • Opioids
  • Technology
    • Conventional Delivery
    • Nanoparticle Enhanced Delivery
  • End User
    • Home Healthcare
    • Hospital
    • Retail Pharmacy
  • Application
    • Cardiovascular Treatment
    • Hormone Replacement
      • Estrogen
      • Testosterone
    • Infectious Diseases
      • Antimicrobial Agents
      • Antiviral Agents
    • Pain Management
      • Acute Pain
      • Chronic Pain
    • Smoking Cessation
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Dentsply Sirona Inc.
  • 3M Company
  • Danaher Corporation
  • Straumann Holding AG
  • Envista Holdings Corporation
  • Align Technology, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Ivoclar Vivadent AG
  • Coltene Holding AG
  • Patterson Companies, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Buccal Cavity Devices Market, by Product Type
8.1. Introduction
8.2. Buccal Film
8.2.1. Mucoadhesive Film
8.2.2. Soluble Film
8.3. Buccal Patch
8.3.1. Matrix Patch
8.3.2. Reservoir Patch
8.4. Buccal Tablet
8.4.1. Controlled-Release Tablet
8.4.2. Instant-Release Tablet
8.5. Gel
8.5.1. Bioadhesive Gel
8.5.2. Hydrogel
8.6. Oral Spray
8.6.1. Metered-Dose Spray
8.6.2. Multi-Dose Spray
9. Buccal Cavity Devices Market, by Drug Class
9.1. Introduction
9.2. Hormones
9.3. Local Anesthetics
9.4. Nicotine
9.5. Opioids
10. Buccal Cavity Devices Market, by Technology
10.1. Introduction
10.2. Conventional Delivery
10.3. Nanoparticle Enhanced Delivery
11. Buccal Cavity Devices Market, by End User
11.1. Introduction
11.2. Home Healthcare
11.3. Hospital
11.4. Retail Pharmacy
12. Buccal Cavity Devices Market, by Application
12.1. Introduction
12.2. Cardiovascular Treatment
12.3. Hormone Replacement
12.3.1. Estrogen
12.3.2. Testosterone
12.4. Infectious Diseases
12.4.1. Antimicrobial Agents
12.4.2. Antiviral Agents
12.5. Pain Management
12.5.1. Acute Pain
12.5.2. Chronic Pain
12.6. Smoking Cessation
13. Americas Buccal Cavity Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Buccal Cavity Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Buccal Cavity Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Dentsply Sirona Inc.
16.3.2. 3M Company
16.3.3. Danaher Corporation
16.3.4. Straumann Holding AG
16.3.5. Envista Holdings Corporation
16.3.6. Align Technology, Inc.
16.3.7. Zimmer Biomet Holdings, Inc.
16.3.8. Ivoclar Vivadent AG
16.3.9. Coltene Holding AG
16.3.10. Patterson Companies, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BUCCAL CAVITY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. BUCCAL CAVITY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. BUCCAL CAVITY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BUCCAL CAVITY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BUCCAL CAVITY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BUCCAL CAVITY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BUCCAL CAVITY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 84. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 85. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 86. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 87. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 88. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 93. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 94. CANADA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 163. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 164. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 165. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 166. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 167. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 172. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 173. GERMANY BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 179. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 185. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 186. FRANCE BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 200. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 202. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 203. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 204. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 205. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 206. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 211. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 212. ITALY BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 213. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 215. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 216. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 217. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 218. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 219. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 224. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 225. SPAIN BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 265. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 267. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 268. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 269. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 270. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 271. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 276. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 291. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 293. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 294. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 295. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 296. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 297. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 298. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 302. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 303. QATAR BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 304. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 306. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 307. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 308. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 309. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 310. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 315. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 316. FINLAND BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Buccal Cavity Devices market report include:
  • Dentsply Sirona Inc.
  • 3M Company
  • Danaher Corporation
  • Straumann Holding AG
  • Envista Holdings Corporation
  • Align Technology, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Ivoclar Vivadent AG
  • Coltene Holding AG
  • Patterson Companies, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.16 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Buccal Cavity Devices - Global Strategic Business Report - Product Image

Buccal Cavity Devices - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Buccal Cavity Devices Market Report 2025 - Product Image

Buccal Cavity Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Buccal Cavity Devices Market 2024-2028 - Product Image

Buccal Cavity Devices Market 2024-2028

  • Report
  • 158 Pages
  • Global
From
Dental Anti-Caries Paste Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dental Anti-Caries Paste Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Dental Caries Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Dental Caries Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From

About the Caries Market

The Buccal Cavity Devices market within the dental industry is a rapidly growing sector. It includes a wide range of products such as dental implants, crowns, bridges, dentures, and orthodontic appliances. These devices are used to restore and maintain the health of the buccal cavity, which includes the teeth, gums, and other oral structures. The market is driven by the increasing prevalence of dental diseases, the growing demand for cosmetic dentistry, and the rising awareness of oral health. The market is segmented based on product type, end-user, and geography. The product type segment includes dental implants, crowns, bridges, dentures, and orthodontic appliances. The end-user segment includes hospitals, dental clinics, and homecare settings. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Some of the major companies in the Buccal Cavity Devices market are Straumann, Dentsply Sirona, Zimmer Biomet, 3M, Henry Schein, and Danaher Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.